US Patent Issued to UNIVERSITY HEALTH NETWORK on April 29 for "FCMR-binding molecules and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,476, issued on April 29, was assigned to UNIVERSITY HEALTH NETWORK (Toronto).

"FCMR-binding molecules and uses thereof" was invented by Richard Brokx (Toronto), Jacqueline M. Mason (Toronto) and Mark R. Bray (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides novel anti-FCMR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease."

The patent was filed on Feb. 14, 2020, under Application No. 17/430,311.

*For further information, including images, charts and tables,...